Last edition
News about
Belgium Firm Eurofins Opens Bio-Pharma Services Campus at Genome Valley
Eurofins, has opened its bio-pharma services campus comprising about one lakh sq ft of laboratory and office space on 15 acres at Genome Valley in Hyderabad.
Venus Remedies Extends its Oncology Portfolio in South Eastern Europe
Oncology drugs constitute the largest proportion of the Serbian pharmaceutical market (projected to reach USD 397.40m in 2023), where Venus Remedies has secured five marketing approvals, all in the oncology space.
Alkem Laboratories Ltd Brands API Business as Alkem Activa
This strategic move underscores the company’s commitment to becoming a formidable global player in the API sector.
SOMAI Pharmaceuticals Receive EU-GMP Certification
SOMAÍ Pharmaceuticals announces that it has received authorisation for its facility located in Lisbon, Portugal from the Portuguese Health Authority INFRAMED.
CordenPharma announces the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.
Samsung Biologics Adds to BMS Manufacturing Partnership with USD 242M Antibody Agreement
After inking and expanding a biosimilar production partnership with Pfizer this summer, Korea’s Samsung Biologics is boosting yet another Big Pharma manufacturing agreement.
PLUSS Launches Two New Temp-Controlled Pharma Packaging Solutions
The pharmaceutical industry in India has long struggled with the availability of premium quality passive shippers that can ensure consistent temperature control.
Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
The brands span four therapy areas of ongoing unmet need associated with CNS disorders - psycholeptic, anxiolytic, anti-epileptic and anti-psychotic.
WHO's Good Manufacturing Norms to be Made Compulsory for All Drug Firms
After allegations that cough syrups produced in India were connected to deaths overseas, the Ministry of Health and Family Welfare (MoHFW) could shortly notify proposed amendments to rules in order to make good manufacturing practice (GMP) compulsory for all pharmaceutical firms, according to a report.
Torrent Pharma in Talks with CVC, Bain Capital for Cipla Bid
Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and Bain Capital to raise up to $1.5 billion to bid for India's Cipla, according to three sources with direct knowledge of the matter.<br />
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy